Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
2nd Chance is a private Arizona-based outpatient behavioral health company focused on addiction psychiatry and general mental health care. The company provides evidence-based treatment for substance use disorders, including opioid and alcohol use disorder, alongside care for co-occurring psychiatric conditions such as anxiety, mood disorders, ADHD, bipolar disorder, PTSD, psychosis, and treatment-resistant depression. Its service model includes medication-assisted treatment, psychiatry, psychotherapy, telehealth, and selected interventional mental health services such as Spravato and transcranial magnetic stimulation. The business operates multiple clinics across the Phoenix metropolitan area and appears to be backed by healthcare-focused private equity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 2nd Chance Treatment Center.